Canada Markets close in 5 hrs

RAMM Pharma Corp. (RAMM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.30000.0000 (0.00%)
As of 11:35AM EST. Market open.
Full screen
Previous Close0.3000
Open0.0000
Bid0.3000 x N/A
Ask0.3700 x N/A
Day's Range0.3000 - 0.3000
52 Week Range0.2100 - 1.1900
Volume0
Avg. Volume145,288
Market Cap37.035M
Beta (5Y Monthly)0.55
PE Ratio (TTM)N/A
EPS (TTM)-0.0720
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    New CBD Regulatory Framework Published by France’s Ministry of Health Opens New Commercial Opportunities for RAMM Pharma’s European Operations

    TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp., including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical products, applauds France’s new regulatory framework for the sale of cannabidiol (“CBD”). Pursuant to the recent announcement, France will allow the utilization of the whole hemp plant, including flowers and leaves, for the industrial production of extracts by setting the THC limit to 0.3% in both bulk ex

  • GlobeNewswire

    RAMM Pharma Corp. Welcomes Proposed Legalization of Recreational Cannabis in Germany

    TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical products, welcomes the announcement by Germany’s recently formed coalition government of its agreement to legalize the sale and consumption of cannabis for recreational use. Germany currently represents the largest medical cannabis market in Europe since legalization in 2017. The European cannabis market

  • GlobeNewswire

    RAMM Pharma Announces Resignation of Director

    TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, announces that Mr. Sergio Martines has resigned from the board of directors of the Company. The Company wishes Mr. Martines success in his future endeavors. About RAMM Pharma Corp. RAMM is a leader in the field of cannabinoid pharmacology and product formulation for can